Literature DB >> 12130589

Hormone replacement therapy.

John C Stevenson, Malcolm I Whitehead.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12130589      PMCID： PMC1123653          DOI： 10.1136/bmj.325.7356.113

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Cardiovascular effects of oestrogens.

Authors:  J C Stevenson
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

2.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.

Authors: 
Journal:  Lancet       Date:  1997-10-11       Impact factor: 79.321

3.  Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina.

Authors:  Steven P Schulman; David R Thiemann; Pamela Ouyang; Nisha C Chandra; Douglas S Schulman; Steven E Reis; Michael Terrin; Sandra Forman; Cicero Piva de Albuquerque; Raymond D Bahr; Susan N Townsend; Rosalie Cosgriff; Gary Gerstenblith
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

4.  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

Authors:  D M Herrington; D M Reboussin; K B Brosnihan; P C Sharp; S A Shumaker; T E Snyder; C D Furberg; G J Kowalchuk; T D Stuckey; W J Rogers; D H Givens; D Waters
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

5.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

6.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
  6 in total
  4 in total

1.  Canadian consensus on hormone replacement therapy. Estrogen and progestin use in postmenopausal women.

Authors: 
Journal:  Can Fam Physician       Date:  2003-02       Impact factor: 3.275

2.  Message about hormone replacement therapy is unclear.

Authors:  J Michael Dixon
Journal:  BMJ       Date:  2002-11-02

3.  Hormone replacement therapy. Logically, long term hormone replacement therapy cannot be recommended.

Authors:  Kishore Shetty
Journal:  BMJ       Date:  2002-11-23

4.  Hormones and dementia - a comparative study of hormonal impairment in post-menopausal women, with and without dementia.

Authors:  Olívia Robusto-Leitao; H Ferreira
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.